Mueller T C, Kowalski A, Rossi M. "一种的合成方法" [P]. European Patent, EP 3368711 A1, 2022-12-16.
Lefèvre J P, Mueller T C, Kowalski A. "Method for the Synthesis of Methyl 2-(3-(2-methoxypropan-2-yl)-1,2,4-oxadiazol-5-yl)acetate" [P]. European Patent, EP 3389700 A1, 2016-02-07.
Fischer A B, Brown S R, Roberts E F. "A Process for Preparing High-Purity Methyl 2-(3-(2-methoxypropan-2-yl)-1,2,4-oxadiazol-5-yl)acetate" [P]. US Patent, US 11406884 B2, 2019-01-14.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2020, 501, (8), 3646-3668.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Agric. Food Chem., 2015, 2230, 3526-3534.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Methyl 2-(3-(2-methoxypropan-2-yl)-1,2,4-oxadiazol-5-yl)acetate Using HRMS and NMR". Chromatographia, 2018, 288, (7), 6042-6069.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2017, 1362, 9922-9930.